Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
This grant funds expanded access for intermediate patient populations suffering from Amyotrophic Lateral Sclerosis (ALS).
About this program
The Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access grant is designed to provide funding for clinical trials that focus on ALS patients who fall into the intermediate category of the disease. This grant aims to facilitate access to investigational therapies for patients who may not qualify for traditional clinical trials but still require treatment options. The program is intended for researchers and institutions that are conducting clinical trials and need financial support to expand their patient access.
Eligibility
Eligible applicants include research institutions and organizations conducting clinical trials related to ALS.